The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension

BACKGROUND: A number of studies have reported the association between the use of angiotensin-converting enzyme inhibitor (ACEI) and angiotensin-II receptor blocker (ARB) medications and the occurrence or severity of coronavirus disease 2019 (COVID-19). Published results are inconclusive, possibly du...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Mingfei, Wang, Ying, Ndiwane, Ndindam, Orner, Michelle B., Palacios, Natalia, Mittler, Brant, Berlowitz, Dan, Kazis, Lewis E., Xia, Weiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971559/
https://www.ncbi.nlm.nih.gov/pubmed/33735262
http://dx.doi.org/10.1371/journal.pone.0248652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7971559/
https://www.ncbi.nlm.nih.gov/pubmed/33735262
http://dx.doi.org/10.1371/journal.pone.0248652

Ejemplares similares